Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Regulatory Toxicology and Pharmacology : RTP|December 13, 2019
Guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devices covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) propertiesW H De Jong, ,
Laboratory Animals|July 19, 2001
Long-term cannulation of the vena cava of rats for blood sampling: local and systemic effects observed by histopathology after six weeks of cannulationW H de Jong, A Timmerman, M T van Raaij
In Vivo (Athens, Greece)|November 1, 1991
Mechanism of BCG induced regression of line 10 hepatocarcinoma in the guinea pigP A Steerenberg, W H De Jong, E J Ruitenberg
Methods (San Diego, Calif.)|June 25, 2002
Medical devices manufactured from latex: European regulatory initiativesW H De Jong, R E Geertsma, J J B Tinkler
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 9, 1999
Detection of immunotoxicity of benzo[a]pyrene in a subacute toxicity study after oral exposure in ratsW H De Jong, E D Kroese, J G Vos, et al.
Cancer Research|December 15, 1989
Immunotherapy of mice with a large burden of disseminated lymphoma with low-dose interleukin 2R A Maas, H F Dullens, W H De Jong, et al.
The Journal of Urology|May 8, 2000
Retrovirus type C in the mouse bladder carcinoma cell line MBT-2E C De Boer, J S Teppema, P A Steerenberg, et al.
Toxicology Letters|February 18, 1999
Risk assessment and immunotoxicologyH Van Loveren, W H De Jong, R J Vandebriel, et al.
Cancer Research|July 1, 1987
Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor modelG Storm, F H Roerdink, P A Steerenberg, et al.
Anticancer Research|May 1, 1991
Intravesical Bacillus Calmette-Guérin treatment for superficial bladder cancer: results after 15 years of experienceA P van der Meijden, P A Steerenberg, W H de Jong, et al.
Pageof 7